Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.

Christina SantellaAlain BittonChristopher FilliterTalat BessissowMaria VutcoviciPeter L LakatosPaul Brassard

Published in: Inflammatory bowel diseases (2021)

Use of anti-TNF therapy was associated with an increased risk of HZ among patients with IBD, particularly among those older than 50 years and those on combination therapy. Prevention strategies for HZ ought to be considered for younger IBD patients commencing treatment.

Keyphrases

combination therapy
patients with inflammatory bowel disease
end stage renal disease
rheumatoid arthritis
newly diagnosed
chronic kidney disease
peritoneal dialysis
physical activity
prognostic factors
mesenchymal stem cells
middle aged
patient reported outcomes
bone marrow
replacement therapy